Enveric Biosciences Stock Forecast - Triple Exponential Smoothing
| ENVB Stock | USD 3.07 0.42 12.03% |
Enveric Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Enveric Biosciences stock prices and determine the direction of Enveric Biosciences's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Enveric Biosciences' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, the RSI of Enveric Biosciences' share price is approaching 40 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Enveric Biosciences, making its price go up or down. Momentum 40
Sell Extended
Oversold | Overbought |
Wall Street Target Price 10 | Quarterly Revenue Growth (0.07) |
Using Enveric Biosciences hype-based prediction, you can estimate the value of Enveric Biosciences from the perspective of Enveric Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The Triple Exponential Smoothing forecasted value of Enveric Biosciences on the next trading day is expected to be 3.26 with a mean absolute deviation of 0.55 and the sum of the absolute errors of 32.25. Enveric Biosciences after-hype prediction price | USD 3.08 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Enveric Biosciences to cross-verify your projections. Enveric Biosciences Additional Predictive Modules
Most predictive techniques to examine Enveric price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Enveric using various technical indicators. When you analyze Enveric charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Enveric Biosciences Triple Exponential Smoothing Price Forecast For the 30th of January
Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Enveric Biosciences on the next trading day is expected to be 3.26 with a mean absolute deviation of 0.55, mean absolute percentage error of 0.97, and the sum of the absolute errors of 32.25.Please note that although there have been many attempts to predict Enveric Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Enveric Biosciences' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Enveric Biosciences Stock Forecast Pattern
| Backtest Enveric Biosciences | Enveric Biosciences Price Prediction | Buy or Sell Advice |
Enveric Biosciences Forecasted Value
In the context of forecasting Enveric Biosciences' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Enveric Biosciences' downside and upside margins for the forecasting period are 0.03 and 17.36, respectively. We have considered Enveric Biosciences' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Enveric Biosciences stock data series using in forecasting. Note that when a statistical model is used to represent Enveric Biosciences stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | 0.1268 |
| MAD | Mean absolute deviation | 0.5465 |
| MAPE | Mean absolute percentage error | 0.1 |
| SAE | Sum of the absolute errors | 32.2453 |
Predictive Modules for Enveric Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Enveric Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Enveric Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Enveric Biosciences After-Hype Price Density Analysis
As far as predicting the price of Enveric Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Enveric Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Enveric Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Enveric Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Enveric Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Enveric Biosciences' historical news coverage. Enveric Biosciences' after-hype downside and upside margins for the prediction period are 0.15 and 17.18, respectively. We have considered Enveric Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Enveric Biosciences is dangerous at this time. Analysis and calculation of next after-hype price of Enveric Biosciences is based on 3 months time horizon.
Enveric Biosciences Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Enveric Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Enveric Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Enveric Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.10 | 14.10 | 0.01 | 0.01 | 9 Events / Month | 6 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
3.07 | 3.08 | 0.33 |
|
Enveric Biosciences Hype Timeline
Enveric Biosciences is currently traded for 3.07. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of -0.01. Enveric is anticipated to increase in value after the next headline, with the price projected to jump to 3.08 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.33%, whereas the daily expected return is currently at 0.1%. The volatility of related hype on Enveric Biosciences is about 15494.51%, with the expected price after the next announcement by competition of 3.06. Net Loss for the year was (9.57 M) with profit before overhead, payroll, taxes, and interest of 8.15 M. Given the investment horizon of 90 days the next anticipated press release will be in about 9 days. Check out Historical Fundamental Analysis of Enveric Biosciences to cross-verify your projections.Enveric Biosciences Related Hype Analysis
Having access to credible news sources related to Enveric Biosciences' direct competition is more important than ever and may enhance your ability to predict Enveric Biosciences' future price movements. Getting to know how Enveric Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Enveric Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| JSPR | Jasper Therapeutics | (0.56) | 11 per month | 0.00 | (0.09) | 7.73 | (9.04) | 31.75 | |
| ONCO | Onconetix | (0.14) | 7 per month | 0.00 | (0.16) | 9.09 | (12.46) | 36.81 | |
| ZVSA | ZyVersa Therapeutics | 0.01 | 8 per month | 5.42 | 0.06 | 14.29 | (10.53) | 86.14 | |
| INDP | Indaptus Therapeutics | 0.01 | 6 per month | 0.00 | (0.05) | 13.58 | (12.56) | 51.64 | |
| SPRC | Scisparc | (0.19) | 8 per month | 0.00 | (0.41) | 3.57 | (12.20) | 30.69 | |
| AZTR | Azitra Inc | 0.01 | 7 per month | 0.00 | (0.12) | 7.14 | (11.36) | 34.09 | |
| SLXN | Biomotion Sciences Ordinary | (0.04) | 5 per month | 0.00 | (0.10) | 15.09 | (8.19) | 37.24 | |
| SCNI | Scinai Immunotherapeutics | (0.03) | 6 per month | 0.00 | (0.04) | 11.65 | (9.29) | 38.82 | |
| SLRX | Salarius Pharmaceuticals | (0.02) | 6 per month | 0.00 | (0.19) | 16.00 | (16.92) | 61.05 | |
| HEPA | Hepion Pharmaceuticals | 0.04 | 9 per month | 0.00 | (0.45) | 13.95 | (25.00) | 78.13 |
Other Forecasting Options for Enveric Biosciences
For every potential investor in Enveric, whether a beginner or expert, Enveric Biosciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Enveric Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Enveric. Basic forecasting techniques help filter out the noise by identifying Enveric Biosciences' price trends.Enveric Biosciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Enveric Biosciences stock to make a market-neutral strategy. Peer analysis of Enveric Biosciences could also be used in its relative valuation, which is a method of valuing Enveric Biosciences by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Enveric Biosciences Market Strength Events
Market strength indicators help investors to evaluate how Enveric Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Enveric Biosciences shares will generate the highest return on investment. By undertsting and applying Enveric Biosciences stock market strength indicators, traders can identify Enveric Biosciences entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.88 | |||
| Day Median Price | 3.07 | |||
| Day Typical Price | 3.07 | |||
| Price Action Indicator | (0.21) | |||
| Period Momentum Indicator | (0.42) | |||
| Relative Strength Index | 40.76 |
Enveric Biosciences Risk Indicators
The analysis of Enveric Biosciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Enveric Biosciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting enveric stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 7.12 | |||
| Standard Deviation | 13.54 | |||
| Variance | 183.24 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Enveric Biosciences
The number of cover stories for Enveric Biosciences depends on current market conditions and Enveric Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Enveric Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Enveric Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Enveric Biosciences Short Properties
Enveric Biosciences' future price predictability will typically decrease when Enveric Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Enveric Biosciences often depends not only on the future outlook of the potential Enveric Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Enveric Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 41.9 K | |
| Cash And Short Term Investments | 2.2 M |
Check out Historical Fundamental Analysis of Enveric Biosciences to cross-verify your projections. For information on how to trade Enveric Stock refer to our How to Trade Enveric Stock guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enveric Biosciences. Projected growth potential of Enveric fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Enveric Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (119.64) | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets | Return On Equity |
Understanding Enveric Biosciences requires distinguishing between market price and book value, where the latter reflects Enveric's accounting equity. The concept of intrinsic value—what Enveric Biosciences' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Enveric Biosciences' price substantially above or below its fundamental value.
It's important to distinguish between Enveric Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Enveric Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Enveric Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.